September 10, 2012

Filed pursuant to Rule 433

Registration No. 333-163858

 

Pricing Term Sheet

 

Merck & Co., Inc.

 

September 10, 2012

 

1.100% Notes due 2018
2.400% Notes due 2022
3.600% Notes due 2042

 

Ratings of the Notes:

 

A1 / AA

Trade Date:

 

September 10, 2012

Settlement Date:

 

September 13, 2012

Bookrunners:

 

Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated

Co-Managers

 

BNP Paribas Securities Corp., Deutsche Bank Securities Inc., RBS Securities Inc., Credit Suisse Securities (USA) LLC, Goldman, Sachs & Co., HSBC Securities (USA) Inc., Morgan Stanley & Co. LLC

Title:

 

1.100% Notes due 2018

 

2.400% Notes due 2022

 

3.600% Notes due 2042

Size:

 

$1,000,000,000

 

$1,000,000,000

 

$500,000,000

Maturity:

 

January 31, 2018

 

September 15, 2022

 

September 15, 2042

Interest Payment Dates:

 

January 31 and July 31, commencing January 31, 2013

 

March 15 and September 15, commencing March 15, 2013

 

March 15 and September 15, commencing March 15, 2013

Coupon:

 

1.100%

 

2.400%

 

3.600%

Benchmark Treasury:

 

0.625% due August 31, 2017

 

1.625% due August 15, 2022

 

3.000% due May 15, 2042

Treasury Yield:

 

0.639%

 

1.654%

 

2.788%

Spread to Benchmark Treasury:

 

T+50 bps

 

T+75 bps

 

T+90 bps

Yield to Maturity:

 

1.139%

 

2.404%

 

3.688%

Price to Public:

 

99.797%

 

99.965%

 

98.411%

Underwriting Discount:

 

35 bps

 

45 bps

 

87.5 bps

Optional Redemption:

 

T+10 bps

 

T+12.5 bps. At any time on or after three months prior to the maturity date, the notes due 2022 will be redeemable as a whole or in part, at our option, at a redemption price equal to 100% of the principal amount of the notes to be redeemed plus accrued and unpaid interest on the notes to be redeemed to the date of redemption.

 

T+15 bps. At any time on or after six months prior to the maturity date, the notes due 2042 will be redeemable as a whole or in part, at our option, at a redemption price equal to 100% of the principal amount of the notes to be redeemed plus accrued and unpaid interest on the notes to be redeemed to the date of redemption.

CUSIP:

 

58933Y AC9

 

589331 AT4

 

589331AS6

ISIN:

 

US58933YAC93

 

US589331AT41

 

US589331AS67

 

Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.

 

The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates.  Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering.  You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov.  Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Citigroup Global Markets Inc. toll-free at 1-877-858-5407, J.P. Morgan Securities LLC collect at 1-212-834-4533 or Merrill Lynch, Pierce, Fenner & Smith Incorporated toll-free at 1-800-294-1322.

 

This pricing term sheet supplements the preliminary form of prospectus supplement issued by Merck & Co., Inc. on September 10, 2012 relating to its Prospectus dated December 18, 2009.